138 related articles for article (PubMed ID: 10381112)
1. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods.
Fuchs PC; Barry AL; Brown SD
J Antimicrob Chemother; 1999 Jan; 43(1):137-40. PubMed ID: 10381112
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility testing quality control studies with fosfomycin tromethamine.
Fuchs PC; Barry AL; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
[TBL] [Abstract][Full Text] [Related]
3. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
Aykut Arca E; Karabiber N
Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
[TBL] [Abstract][Full Text] [Related]
4. Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.
Barry AL; Pfaller MA; Fuchs PC; Tenover FC; Reller LB; Allen SD; Hardy DJ; Gerlach EH
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):352-6. PubMed ID: 8354302
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012).
Lai B; Zheng B; Li Y; Zhu S; Tong Z
BMC Infect Dis; 2014 Feb; 14():66. PubMed ID: 24502648
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of disk susceptibility testing of fosfomycin tromethamine.
Pfaller MA; Barry AL; Fuchs PC
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):67-70. PubMed ID: 8359009
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four
Karlowsky JA; Lagacé-Wiens PRS; Laing NM; Baxter MR; Adam HJ; Zhanel GG
J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32817224
[TBL] [Abstract][Full Text] [Related]
8. Use of Fosfomycin Etest To Determine
Karlowsky JA; Baxter MR; Golden AR; Adam HJ; Walkty A; Lagacé-Wiens PRS; Zhanel GG
J Clin Microbiol; 2021 Nov; 59(12):e0163521. PubMed ID: 34495708
[TBL] [Abstract][Full Text] [Related]
9. Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species.
Goer A; Blanchard LS; Van Belkum A; Loftus KJ; Armstrong TP; Gatermann SG; Shortridge D; Olson BJ; Meece JK; Fritsche TR; Pompilio M; Halimi D; Franceschi C
J Clin Microbiol; 2022 Jul; 60(7):e0002122. PubMed ID: 35736011
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
Tempera G; Mirabile M; Mangiafico A; Caccamo M; Bonfiglio G
J Chemother; 2004 Apr; 16(2):216-7. PubMed ID: 15216960
[No Abstract] [Full Text] [Related]
11. Medium compositions and culture conditions for the assay of fosfomycin susceptibility by Etest.
Horii T; Kimura T; Odagiri T; Shibayama K; Ohta M
J Infect Chemother; 2000 Mar; 6(1):30-4. PubMed ID: 11810528
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.
Lu CL; Liu CY; Huang YT; Liao CH; Teng LJ; Turnidge JD; Hsueh PR
Antimicrob Agents Chemother; 2011 Sep; 55(9):4295-301. PubMed ID: 21670185
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics.
Butcu M; Akcay SS; Inan AS; Aksaray S; Engin DO; Calisici G
J Infect Chemother; 2011 Aug; 17(4):575-8. PubMed ID: 21287226
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
Traub WH; Geipel U; Leonhard B
Chemotherapy; 1998; 44(4):217-29. PubMed ID: 9681198
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial spectrum of fosfomycin trometamol.
Barry AL; Brown SD
J Antimicrob Chemother; 1995 Jan; 35(1):228-30. PubMed ID: 7768774
[No Abstract] [Full Text] [Related]
16. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
17. In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis.
Superti S; Dias CA; d'Azevedo PA
Braz J Infect Dis; 2009 Apr; 13(2):123-4. PubMed ID: 20140356
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: a prospective study.
Sahni RD; Balaji V; Varghese R; John J; Tansarli GS; Falagas ME
Future Microbiol; 2013 May; 8(5):675-80. PubMed ID: 23642120
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of fosfomycin against vancomycin-resistant enterococci.
Allerberger F; Klare I
J Antimicrob Chemother; 1999 Feb; 43(2):211-7. PubMed ID: 11252326
[TBL] [Abstract][Full Text] [Related]
20. Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.
Hirsch EB; Raux BR; Zucchi PC; Kim Y; McCoy C; Kirby JE; Wright SB; Eliopoulos GM
Int J Antimicrob Agents; 2015 Dec; 46(6):642-7. PubMed ID: 26498988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
